InvestorsHub Logo
Post# of 252254
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: dewophile post# 135568

Wednesday, 01/25/2012 2:35:38 AM

Wednesday, January 25, 2012 2:35:38 AM

Post# of 252254
Looked at the few publications they have. They were studying the molecular mechanism of HCV NS3-4A resistance to PIs. So, my guess is they either used their knowledge to design a PI candidate that can overcome resistance or some new molecule that helps circumvent resistance to PIs or some new unrelated MoA to be used in combo with current approved anti virus treatment. I now tend against the first.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.